← Evidence map

ReviewCNS drugs2016

Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Mohammad M KhanPubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27193386